Prognostic Value of Pre‐Treatment Diffusion Kurtosis Imaging for Progression‐Free Survival Prediction in Advanced Nasopharyngeal Carcinoma
Pretreatment MK serves as a robust noninvasive biomarker for long-term PFS in NPC. Integration with Clinical Stage and NAC regimens enhances prognostic stratification, supporting personalized therapeutic strategies.
Authors
- Zheng Xiang (ORCID: https://orcid.org/0000-0001-8161-5194)
- Shizhong Wu
- Ren Wang (ORCID: https://orcid.org/0000-0002-4181-1710)
- Caixia Wu (ORCID: https://orcid.org/0000-0003-1178-1108)
- Dechun Zheng (ORCID: https://orcid.org/0000-0001-8768-1627)
Institutions
- Fujian Medical University (CN)
- Fujian Provincial Cancer Hospital (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1002/cam4.70883
- Primary Topic
- Bone and Joint Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Fujian Province